Elena Massarotti, MD
Enriched profileRheumatologist; Clinical Director, BWH Lupus Center; Director, Clinical Trials Program; Associate Professor of Medicine, Harvard Medical School · Brigham and Women's Hospital
Elena Massarotti is Rheumatologist; Clinical Director, BWH Lupus Center; Director, Clinical Trials Program; Associate Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital. OpenAlex indexes 54 publications with 4,811 citations (h-index 26); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 12 Oct 2026
Overview
Updated 14 Oct 2026
Elena Massarotti, MD, is Rheumatologist at Brigham and Women's Hospital. The public record shows 54 publications with 4,811 citations (h-index 26), centered on Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Autoimmune and Inflammatory Disorders Research. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 5 companies.
- Most recent indexed publication: 2019 · The Journal of rheumatology
- Top research focus: Rheumatoid Arthritis Research and Therapies
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 33.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Lupus Landmark Study: A Prospective Registry and Biorepository
Sponsor: Lupus Research Alliance
- Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
Sponsor: Brigham and Women's Hospital
Industry payments
Updated 14 Oct 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- EMD Serono Research & Development Institute, Inc.Program year20253 payments
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
42%Folate Analog Metabolic Inhibitor15%Methotrexate95%Rasuvo5%Part D<11 patientsTNF inhibitor12.7%Humira(Cf) Pen41%Enbrel Sureclick34%Enbrel19%Humira(Cf)7%Part D<11 patients+ 7 more classes in this area
Nervous system
17.7%Opioid Agonist11%Oxycodone Hcl45%Tramadol Hcl44%Oxycontin12%Part D<11 patientsGabapentinoids4.4%Gabapentin100%Part D≥31 patients+ 2 more classes in this area
Metabolism & gastrointestinal
14.5%Corticosteroid10.2%Prednisone100%Part D≥66 patientsProton pump inhibitor2%Omeprazole100%Part D≥13 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.
The Journal of rheumatology
Article2019 - Mixed-effects association of single cells identifies an expanded effector CD4(+) T cell subset in rheumatoid arthritis.
Science translational medicine
Article2018
Most-cited works
by citation count (OpenAlex)- 01Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritisArticle1,117 citations2017
- 02Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle ProductionArticle1,088 citations2010
- 03The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritisArticle227 citations2002
- 04
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
- Board certified
American Board of Internal Medicine (Internal Medicine and Rheumatology)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.bwh.harvard.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
Marc Sabatine, MD
Brigham and Women's Hospital
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital